Jail-Based Impact of Crime Intervention

Substance Abuse Clinical Trial

— IOC  

Official title:

Phase 2 RCT of Jail-Based Impact of Crime Intervention to Reduce Recidivism, Substance Abuse and HIV Risk Behavior

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01378936
• Other study ID #: R01DA014694-11
• Secondary ID: R01DA014694
• Status: Active, not recruiting
• Phase: Phase 2
• First received: June 17, 2011
• Last updated: May 3, 2013
• Start date: August 2009
• Est. completion date: June 2016

Study information

• Verified date: May 2013
• Source: George Mason University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate whether the Impact of Crime (IOC) group intervention with jail inmates reduces post-release recidivism, substance abuse, and HIV risk behavior.

Description:

This project imports social-personality theory and research on moral emotions and cognitions to the applied problems of crime, substance abuse, and HIV risk behavior. The primary aim of this study, a Phase 2 Randomized Clinical Trial (RCT) of the restorative justice-inspired Impact of Crime (IOC) group intervention, is to examine the efficacy of treatment and to determine if changes in moral emotions and cognitions serve as mechanisms of action, explaining the impact of treatment involvement on reductions in post-release recidivism, substance abuse, and HIV risk behavior.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 200
• Est. completion date: June 2016
• Est. primary completion date: December 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Must be 18 years or older

• Must be male

• Must be currently incarcerated jail inmate

• Must be sentenced

• Sentence must be short enough to serve out sentence at ADC

• Release date must follow projected final session of treatment

• Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions

• Must be assigned to the jail's "general population"

Exclusion Criteria:

• Actively psychotic

• Assigned "keep separate" from other group members

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Criminogenic Thinking
• Empathy
• Guilt
• HIV Risk
• Shame
• Substance Abuse
• Substance-Related Disorders

Intervention

Behavioral:
• MI plus IOC group intervention
45 minute Motivational Interview plus 16 session IOC intervention
• Motivational Interview only
45 minute Motivational Interview session

Locations

Country	Name	City	State
United States	Fairfax County Adult Detention Center	Fairfax	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
George Mason University	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recidivism - Self report of arrests and undetected crimes		3 months post-release	No
Primary	Recidivism - Self report of arrests and undetected crimes		1 yr post-release	No
Primary	Recidivism - Self report of arrests and undetected crimes		3 yr post-release	No
Primary	Recidivism - Self report of arrests and undetected crimes		5 yr post-release	No
Primary	Recidivism -- official FBI records of arrests		1 yr post-release	No
Primary	Recidivism -- official FBI records of arrests		3 yr post-release	No
Primary	Recidivism -- official FBI records of arrests		5 yr post-release	No
Secondary	Changes in self-reported shame-proneness from baseline		changes from baseline to post tx and 3 mo, 1 yr, 3yr and 5 yr post-release	No
Secondary	Changes in self-reported guilt proneness from baseline		changes from baseline to post tx, and 3 mo, 1 yr, 3 yr, 5 yr post-release	No
Secondary	Changes from self-reported empathy from baseline		changes from baseline to post tx, 3 mo, 1 yr, 3 yr, 5 yr post-release	No
Secondary	Changes from self-reported criminogenic thinking at baseline		changes from baseline to post tx, and 3 mo, 1 yr, 3 yr, 5 yr post-release	No
Secondary	Changes in self-reported substance use and dependence from 1 yr pre-incarceration		changes from pre-incarceration to 3 mo, 1 yr, 3 yr, 5 yr post-release	No
Secondary	Changes in self-reported HIV risk behavior (sex and IDU) from 1 year pre-incarceration		changes from pre-incarceration to 3 mo, 1 yr, 3 yr, 5 yr post-release	No